We are aware of current issues with the ONS login. Please clear your device history/cache/cookies before attempting to log in. Thank you for your patience as we address this issue.

Oncology Drug Reference Sheet: 5-Fluorouracil

By: Erin Dickman, DNP, RN, OCN®

Published In: Voice

Publication Date: 2024-07-23

Description

A mainstay of many cancer treatments for decades, 5-fluorouracil injection package inserts were updated in March 2024 through the U.S. Food and Drug Administration’s Project Renewal. The revisions add pharmacogenomics information and a safety warning about severe adverse reactions in patients with DPD deficiency.

View Article @ voice.ons.org

ONS Drug Education

Short summaries of newly approved oncology-related therapies or drugs with new indications.

View All Drug Education

Oncology Drug Reference Sheet: 5-Fluorouracil

Description

ONS Drug Education

Related Topics